These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 26572146)
21. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue. Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813 [TBL] [Abstract][Full Text] [Related]
22. Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC. Kanazawa T; Misawa K; Misawa Y; Maruta M; Uehara T; Kawada K; Nagatomo T; Ichimura K Mol Med Rep; 2014 Sep; 10(3):1289-94. PubMed ID: 25017118 [TBL] [Abstract][Full Text] [Related]
23. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex. Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404 [TBL] [Abstract][Full Text] [Related]
24. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494 [TBL] [Abstract][Full Text] [Related]
25. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma. Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; de Vos L; Franzen A; Schröck F; Bootz F; Kristiansen G; Schröck A; Dietrich D Oncotarget; 2016 Nov; 7(46):75827-75838. PubMed ID: 27716615 [TBL] [Abstract][Full Text] [Related]
26. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma. Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769 [TBL] [Abstract][Full Text] [Related]
27. Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation. Misawa K; Mima M; Satoshi Y; Imai A; Mochizuki D; Ishikawa R; Kita J; Yamaguchi Y; Endo S; Misawa Y; Mineta H J Transl Med; 2020 Jan; 18(1):31. PubMed ID: 31969157 [TBL] [Abstract][Full Text] [Related]
28. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610 [TBL] [Abstract][Full Text] [Related]
29. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Martone T; Gillio-Tos A; De Marco L; Fiano V; Maule M; Cavalot A; Garzaro M; Merletti F; Cortesina G Clin Cancer Res; 2007 Sep; 13(17):5089-94. PubMed ID: 17785562 [TBL] [Abstract][Full Text] [Related]
30. Promoter methylation of galanin receptors as epigenetic biomarkers for head and neck squamous cell carcinomas. Kanazawa T; Misawa K; Shinmura K; Misawa Y; Kusaka G; Maruta M; Sasaki T; Watanabe Y; Carey TE Expert Rev Mol Diagn; 2019 Feb; 19(2):137-148. PubMed ID: 30640567 [TBL] [Abstract][Full Text] [Related]
31. Galanin is an epigenetically silenced tumor suppressor gene in gastric cancer cells. Yoon D; Bae K; Lee MK; Kim JH; Yoon KA PLoS One; 2018; 13(2):e0193275. PubMed ID: 29462183 [TBL] [Abstract][Full Text] [Related]
32. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Zuo C; Zhang H; Spencer HJ; Vural E; Suen JY; Schichman SA; Smoller BR; Kokoska MS; Fan CY Otolaryngol Head Neck Surg; 2009 Oct; 141(4):484-90. PubMed ID: 19786217 [TBL] [Abstract][Full Text] [Related]
33. Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancers. Avincsal MO; Jimbo N; Fujikura K; Shinomiya H; Otsuki N; Morimoto K; Furukawa T; Morita N; Maehara R; Itoh T; Nibu KI; Zen Y Histopathology; 2018 Apr; 72(5):826-837. PubMed ID: 29143365 [TBL] [Abstract][Full Text] [Related]
34. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma. Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145 [TBL] [Abstract][Full Text] [Related]
35. Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galanin receptor type II and III. Kim DK; Yun S; Son GH; Hwang JI; Park CR; Kim JI; Kim K; Vaudry H; Seong JY Endocrinology; 2014 May; 155(5):1864-73. PubMed ID: 24517231 [TBL] [Abstract][Full Text] [Related]
36. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer. Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas. Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089 [TBL] [Abstract][Full Text] [Related]
38. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447 [TBL] [Abstract][Full Text] [Related]